HomeAVIR • NASDAQ
add
Atea Pharmaceuticals Inc
Previous close
$3.30
Day range
$3.10 - $3.29
Year range
$2.46 - $4.14
Market cap
249.18M USD
Avg Volume
290.23K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 39.00M | 32.87% |
Net income | -37.16M | 8.29% |
Net profit margin | — | — |
Earnings per share | -0.44 | 8.33% |
EBITDA | -41.32M | -16.97% |
Effective tax rate | -0.56% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 379.71M | -24.39% |
Total assets | 391.60M | -23.27% |
Total liabilities | 27.19M | -19.83% |
Total equity | 364.42M | — |
Shares outstanding | 79.36M | — |
Price to book | 0.73 | — |
Return on assets | -24.91% | — |
Return on capital | -26.61% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -37.16M | 8.29% |
Cash from operations | -32.87M | 22.11% |
Cash from investing | 15.29M | -87.74% |
Cash from financing | -14.09M | — |
Net change in cash | -31.67M | -138.40% |
Free cash flow | -20.38M | 2.53% |
About
Founded
2012
Headquarters
Website
Employees
56
